Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years

Yee, Chee-Seng; Su, Li; Toescu, V.; Hickman, Richard A.; Situnayake, Deva; Bowman, Simon; Farewell, Vernon; Gordon, Caroline

doi:10.1093/rheumatology/keu412

Cited by 103 publications

(76 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite improvement in survival over the last 40 years, lupus patients still die on average 25 years earlier than the mean for women and men in the UK (2).…”

Section: Executive Summary (~1573/1500 Words With Loe Gor and Soa)mentioning

confidence: 99%

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary

et al. 2017

Self Cite

View full text Add to dashboard Cite

“…Despite improvement in survival over the last 40 years, lupus patients still die on average 25 years earlier than the mean for women and men in the UK (2).…”

Section: Executive Summary (~1573/1500 Words With Loe Gor and Soa)mentioning

confidence: 99%

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary

et al. 2017

Self Cite

View full text Add to dashboard Cite

“…В дебюте заболевания в 38,3% случаев выявлен ВН, который, несмотря на стан-дартное лечение, ассоциировался с развитием ХПН и вы-сокой смертностью. Предикторами неблагоприятного про-гноза являлись возраст дебюта заболевания после 40 лет, на-личие НП жизненно важных органов, а также использова-ние высоких доз ГК [1,2,30,41,42].…”

Section: данные когортных исследований и регистров за рубежомunclassified

“…Несмотря на огром-ные достижения последних десятилетий, в ре-зультате которых 10-летняя выживаемость увеличилась более чем в два раза, смертность при СКВ превышает популяционную в не-сколько раз [1][2][3]. По данным большинства исследований, основными причинами высо-кой летальности являются активность СКВ, инфекции и развитие необратимых поврежде-ний (НП) жизненно важных органов [4,5].…”

unclassified

The Registry of Systemic Lupus Erythematosus Patients, a Eurasian Cohort (Renaissance)

Асеева¹,

Дубиков²,

Левашева³

et al. 2016

rsp

View full text Add to dashboard Cite

“…Background: Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs in women of childbearing age, and has high risk for adverse pregnancy outcomes (APOs) (1,2). Moreover, it is unclear whether maternal SLE influences the growth and development of children born from SLE mothers.…”

mentioning

confidence: 99%

“…A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199:127.e1-6 [2]. Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016.…”

mentioning

confidence: 99%

Ab0561 Risk Factors for Adverse Pregnancy Outcomes and Low Risk Factors for Adverse Pregnancy Outcomes and Low Apgar Scores of Newborns in Women With Systemic Lupus Erythematosus

Shimada

Wakiya

Mansour

et al. 2019

Abstracts Accepted for Publication

View full text Add to dashboard Cite

Background:Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs in women of childbearing age, and has high risk for adverse pregnancy outcomes (APOs) (1,2). Moreover, it is unclear whether maternal SLE influences the growth and development of children born from SLE mothers. Apgar scores at five minutes is a predictive factor of neurological development of newborns. However, there is no report about the association between maternal SLE and Apgar score of newborns.Objectives:The aim of this study was to identify risk factors for APOs and for low Apgar scores of newborns from SLE mothers.Methods:We investigated 50 SLE patients who were delivered from May 2006 to December 2018 in our institution. We examined retrospectively regarding APOs including spontaneous abortions, preterm births, premature rupture of membranes (PROM), light-for-date (LFD) newborns, and low Apgar scores of newborns. We analyzed the association between disease activity, laboratory findings, treatment agents, and APOs or Apgar scores.Results:As for APOs of SLE mothers, cases with preterm births showed higher SLE disease activity index (SLEDAI) during the first trimester (P = 0.01) and higher titers of anti-double-stranded DNA (anti-dsDNA) antibodies at the time of conception (P < 0.01) compared to full-term births. In these cases, mean glucocortitcoid doses during pregnancy (P = 0.02) and the rate of treatment intensification (P < 0.01) was higher than full-term birth. In the mothers who delivered LFD newborns, serum complement levels at conception were lower than in those with non-LFD newborns (C3: P = 0.02; CH50: P = 0.05). Cases with spontaneous abortions and PROMs did not differ significantly from the cases without spontaneous abortions and PROMs. Apgar scores at one minute were correlated with SLEDAI during the third trimester (P < 0.01) and with the titer of anti-dsDNA antibodies at conception (P < 0.01). Additionally, Apgar scores at five minutes were correlated with the titer of anti-dsDNA antibodies (P < 0.01). In multivariate analysis, there were significant association between Apgar scores at five minutes and the titer of anti-dsDNA antibodies (P < 0.01, Table 1).Abstract AB0561 Table 1 Multivariate analysis of risk factor for Apgar score at 5 minutesConclusion:In SLE, immunological abnormalities at conception, high SLEDAI and glucocorticoid doses were risk factors for preterm birth and having a LFD newborn. Apgar scores at five minutes were significantly associated with the titer of anti-dsDNA antibodies. Minimizing disease activity before pregnancy may decrease risks for mothers and their newborns. In preconception counseling, it is important for rheumatologists to explain these risk factors to patients with SLE who hope to conceive. There is a need for long-term follow-up studies focusing on the neurological development of children born from SLE mothers.References[1] Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199:127.e1-6.[2] Bundhu...

show abstract

Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years

Abstract: SLE patients have premature mortality. Active disease, corticosteroid exposure and CYC exposure were independently associated with the development of damage. Damage accrual is more likely to occur in early disease.

Cited by 103 publications

References 21 publications

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary

The Registry of Systemic Lupus Erythematosus Patients, a Eurasian Cohort (Renaissance)

Ab0561 Risk Factors for Adverse Pregnancy Outcomes and Low Risk Factors for Adverse Pregnancy Outcomes and Low Apgar Scores of Newborns in Women With Systemic Lupus Erythematosus

Contact Info

Product

Resources

About